Clinical Trial Results

Showing: All studies [change]
Condition: Hypertension Location: Alabama 20 trials found
New Search
Filter
Trial Phase
Study Type
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
PHASE2INTERVENTIONAL Huntsville, Alabama +4 more
RECRUITING
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
PHASE3INTERVENTIONAL Fairhope, Alabama +4 more
RECRUITING
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
NAINTERVENTIONAL New Haven, Connecticut +2 more
RECRUITING
Global Paradise System US Post Approval Study
N/AOBSERVATIONAL Long Beach, California +4 more
RECRUITING
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
PHASE3INTERVENTIONAL Alexander City, Alabama +4 more
RECRUITING
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
PHASE3INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease
NAINTERVENTIONAL Rochester, New York
RECRUITING
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NAINTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
N/AOBSERVATIONAL Phoenix, Arizona +4 more
RECRUITING
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
PHASE3INTERVENTIONAL Fresno, California +4 more
RECRUITING
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
NAINTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Pulmonary Hypertension Association Registry
N/AOBSERVATIONAL Phoenix, Arizona +4 more
RECRUITING
Albumin To Enhance Recovery After Acute Kidney Injury
PHASE4INTERVENTIONAL Calgary, Alberta +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type